BOSTON (MarketWatch) -- Shares of OSI Pharmaceuticals traded as much as 8% lower Monday, a day ahead of a scheduled hearing for its Tarceva drug to be conducted by a Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback